1. Morrison D, Prokopchuk-Gauk O, Co-Chairs for the NAC-CCNMT Irradiation Working Group. Recommendations for use of irradiated blood components in Canada: A NAC and CCNMT collaborative initiative. National Advisory Committee on Blood and Blood Products. October 17, 2017; revised May 14, 2018. https://www.nacblood.ca/resources/guidelines/downloads/Recommendations_Irradiated_Blood_Components.pdf. Accessed 27 Aug 2021.
2. Foukaneli T, Kerr P, Bolton-Maggs PH, Cardigan R, Coles A, Gennery A, et al. Guidelines on the use of irradiated blood components. Br J Haematol. 2020;191:704–24.
3. Non-Isotopic Alternative Technologies Working Group. Non-radioisotopic alternative technologies white paper. U.S. Department of Homeland Security Cybersecurity and Infrastructure Security Agency (CISA). September 2019. https://www.cisa.gov/sites/default/files/publications/19_1211_cisa_non_radioisotopic_alternative_technologies-white_paper.pdf. Accessed 30 Aug 2021.
4. Mintz P, Wehrli G. Irradiation eradication and pathogen reduction. Ceasing cesium irradiation of blood products. Bone Marrow Transplant. 2009;44:205–11.
5. Pritchard AE, Shaz BH. Survey of irradiation practice for the prevention of transfusion-associated graft-versus-host disease. Arch Pathol Lab Med. 2016;140(10):1092–7.